 | PRD_001186 | Name: | Myosin-A, stapled peptide | Formula: | C97 H175 N31 O23 S | Description: | SYNTHESISED PEPTIDE MIMIC OF PLASMODIUM FALCIPARUM MYOSIN A TAIL | Definition date: | 2013-11-06 | Last modified: | 2017-12-15 |
|
 | PRD_002230 | Name: | L-alpha-aspartyl-6-azaniumyl-L-norleucyl-O-phosphono-L-seryl-L-isoleucyl-L-alpha-glutamyl-L-valyl-N-{(3R)-6-{[amino(iminio)methyl]amino}-1-[2-(methoxycarbonyl)-3,5-dimethylphenyl]-2-oxohexan-3-yl}glycinamide | Formula: | C48 H81 N12 O18 P | Definition date: | 2016-05-04 | Last modified: | 2017-12-15 |
|
 | PRD_002275 | Formula: | C35 H59 N14 O13 | Definition date: | 2017-06-14 | Last modified: | 2017-12-15 |
|
 | PRD_002277 | Name: | N-{(2S,4R)-2-[(1R)-3-amino-1-({N-[(2R)-2-{(1R)-1-[(N-{(2S)-2-[(1S)-3-amino-1-({N-[(3S,6R)-3-(3-amino-3-oxopropyl)-6-(hydroxymethyl)-5-oxo-3,4,5,6-tetrahydropyrazin-2-yl]-L-seryl-L-prolylglycyl}amino)-3-oxopropyl]-2,3-dihydro-1,3-thiazole-4-carbonyl}-L-alanyl)amino]-2-hydroxyethyl}-2,3-dihydro-1,3-thiazole-4-carbonyl]-L-seryl}amino)-3-oxopropyl]-1,3-oxazolidine-4-carbonyl}-L-alanyl-L-seryl-N-{(1S)-3-amino-1-[(2S)-4-{[(2S,3S)-3-hydroxy-1-oxobutan-2-yl]carbamoyl}-2,3-dihydro-1,3-thiazol-2-yl]-3-oxopropyl}-L-alaninamide | Formula: | C64 H93 N23 O25 S3 | Definition date: | 2017-08-30 | Last modified: | 2017-12-15 |
|
 | PRD_002274 | Name: | N-[(6aR,12R,15aR,17R,21R,23aR)-17,21-dimethyl-6,11,15,20,23-pentaoxooctadecahydro-2H,6H,11H,15H-pyrido[2,1-i]dipyrrolo[2,1-c:2',1'-l][1,4,7,10,13]oxatetraazacyclohexadecin-12-yl]-Nalpha-[(2E)-pent-2-enoyl]-L-phenylalaninamide | Formula: | C37 H50 N6 O8 | Definition date: | 2017-06-21 | Last modified: | 2017-06-21 |
|
 | PRD_002261 | Formula: | C92 H138 N27 O24 S | Description: | single helix from the B-domain of protein A bound to IgG1 Fc | Definition date: | 2017-05-24 | Last modified: | 2017-05-24 |
|
 | PRD_001077 | Name: | Cul1WHB-Dcn1P-stapled acetylated | Formula: | C71 H133 N17 O16 Se | Definition date: | 2012-12-12 | Last modified: | 2017-05-04 |
|
 | PRD_001131 | Name: | GRAMICIDIN A | Formula: | C90 H133 N19 O17 | Description: | GRAMICIDIN A IS A HEXADECAMERIC HELICAL PEPTIDE WITH ALTERNATING D,L CHARACTERISTICS.
THE N-TERM IS FORMYLATED (RESIDUE 0). THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | Definition date: | 2013-07-02 | Last modified: | 2017-05-04 |
|
 | PRD_001132 | Name: | CYCLOSPORIN D | Formula: | C63 H113 N11 O12 | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI. CYCLOSPORIN D IS A NATURAL ANALOG OF CYCLOSPORIN A
OBTAINED FROM A DIFFERENT NUTRIENT BROTH AND
DIFFERS FROM CYCLOSPORIN IN RESIDUE 6 (ABA6VAL) | Definition date: | 2013-07-02 | Last modified: | 2017-05-04 |
|
 | PRD_001238 | Name: | PEPSTATIN ANALOGUE ISOVALERYL-VAL-VAL-STA-O-ET | Formula: | C25 H47 N3 O6 | Definition date: | 2014-06-04 | Last modified: | 2017-05-04 |
|
 | PRD_002186 | Name: | 6-ammonio-N-[3-(9H-fluoren-9-yl)propanoyl]-L-norleucyl-6-ammonio-L-norleucyl-L-alpha-glutamyl-L-threonyl-L-alpha-glutamyl-L-valine | Formula: | C47 H70 N8 O13 | Definition date: | 2016-08-17 | Last modified: | 2016-08-17 |
|
 | PRD_002231 | Name: | N~2~-{(4R,7S,10R,13R,16R,19S,24R)-19,24-diamino-16-(3-{[amino(iminio)methyl]amino}propyl)-7-(4-azaniumylbutyl)-10-[(1R)-1-hydroxyethyl]-13-[(1H-indol-3-yl)methyl]-6,9,12,15,18,23-hexaoxo-1,2-dithia-5,8,11,14,17,22-hexaazacyclopentacosane-4-carbonyl}-L-leucinamide | Formula: | C43 H73 N15 O9 S2 | Definition date: | 2016-06-01 | Last modified: | 2016-06-01 |
|
 | PRD_001260 | Name: | PAMK PEPTIDE Inhibitor | Formula: | C48 H80 N12 O15 | Definition date: | 2016-05-04 | Last modified: | 2016-05-04 |
|
 | PRD_002162 | Name: | N-[(4-carbamimidamidobutyl)carbamoyl]-L-seryl-N-[(2S)-5-{[amino(iminio)methyl]amino}-1-oxopentan-2-yl]-L-valinamide | Formula: | C20 H41 N10 O5 | Definition date: | 2016-05-04 | Last modified: | 2016-05-04 |
|
 | PRD_002222 | Name: | N-(3-bromo-4-methoxybenzene-1-carbonyl)-beta-alanyl-3-(8-phenyloctyl)-L-histidyl-L-seryl-O-phosphono-L-threoninamide | Formula: | C38 H53 Br N7 O11 P | Definition date: | 2016-02-24 | Last modified: | 2016-02-24 |
|
 | PRD_002200 | Name: | N-benzoyl-L-leucyl-L-leucine | Formula: | C19 H28 N2 O4 | Definition date: | 2016-02-17 | Last modified: | 2016-02-17 |
|
 | PRD_001259 | Name: | acyclic trypsin inhibitor | Formula: | C67 H108 N18 O19 S2 | Definition date: | 2016-01-13 | Last modified: | 2016-01-13 |
|
 | PRD_002208 | Formula: | C43 H66 N6 O8 | Definition date: | 2015-12-16 | Last modified: | 2015-12-16 |
|
 | PRD_000929 | Name: | N-acetyl-L-valyl-L-alpha-glutamyl-N-[(2S)-1-carboxy-3-hydroxypropan-2-yl]-L-isoleucinamide | Formula: | C22 H38 N4 O9 | Definition date: | 2015-12-02 | Last modified: | 2015-12-02 |
|
 | PRD_002182 | Name: | [amino({3-[(3R,6R,9S,12R,15S,21R,24R,27S,30R,33S,36R,39S)-39-amino-36-(4-ammoniobutyl)-12,33-bis(2-carboxyethyl)-30-(4-hydroxybenzyl)-6-[(1S)-1-hydroxyethyl]-3,21-bis(hydroxymethyl)-27-methyl-9,24-bis(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29,32,35,38-tridecaoxo-1,4,7,10,13,16,19,22,25,28,31,34,37-tridecaazacyclodotetracontan-15-yl]propyl}amino)methylidene]ammonium | Formula: | C63 H106 N18 O21 | Definition date: | 2015-10-28 | Last modified: | 2015-10-28 |
|
 | PRD_000841 | Name: | CARBOXYPROPYL-BETA-THIOGALACTOSIDE-LYS-PRO-LEUNH2 | Formula: | C26 H48 N5 O9 S | Definition date: | 2015-09-16 | Last modified: | 2015-09-16 |
|
 | PRD_001241 | Name: | (BOC)LPA(B27) PEPTIDE | Formula: | C23 H42 N4 O6 S | Definition date: | 2015-09-09 | Last modified: | 2015-09-09 |
|
 | PRD_002106 | Name: | L-alpha-glutamyl-L-isoleucyl-N-[(2S,3S)-4-{[(1S)-1-carboxybutyl]amino}-3-hydroxy-4-oxo-1-(thiophen-2-yl)butan-2-yl]-3-thiophen-2-yl-L-alaninamide | Formula: | C31 H45 N5 O9 S2 | Definition date: | 2015-07-29 | Last modified: | 2015-07-29 |
|
 | PRD_000815 | Name: | peptide ACE-THR-VAL-ALC-HIS-H | Formula: | C26 H43 N6 O6 | Definition date: | 2012-12-12 | Last modified: | 2015-07-27 |
|
 | PRD_001000 | Name: | peptide ACE-SER-ALA-VAL-LEU-HIS-H | Formula: | C25 H42 N7 O7 | Definition date: | 2012-12-12 | Last modified: | 2015-07-21 |
|